Calculating the aortic valve force and generated power by a specific cardiac assist device (AVICENA) in different counterpulsation
- 77 Downloads
AVICENA is a specific cardiac assist device which is used in the cases with left ventricular failure and implanted in the aorta that can pump the blood flow with more strength into the circulatory system. Although this device can increase the power of blood flow by its inflation and deflation, it may apply some extra force to the aortic valve while working in the heart. This study aims at investigating these amounts of generated power and aortic valve force in different patterns of device counterpulsation using FSI. In this study, only six different displacement factor curves applied to the balloon as well as only one boundary condition applied to the inlet and outlet of the aorta are considered. The outcome of this study helps to improve the design of this device in a way that it may produce more power and less force on the aortic valve.
KeywordsAVICENA Counterpulsation FSI Displacement factor curve
Authors acknowledge the Iran University of Science and Technology for funding this project. They appreciate the cooperation of Prof. Hormoz Mehmanesh and also their colleagues at Tehran Heart Center (THC) for their intellectual guidance during working on this project.
- 2.O’Connell JB (1994) Economic impact of heart failure in the United States: time for a different approach. J Hear Lung Transpl 13:107–112Google Scholar
- 3.Hunt SA (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46:e1–e82MathSciNetCrossRefGoogle Scholar
- 6.Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS et al (2002) ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) Developed in Collaboration with the International Society for Heart and Lung Transplantation Endorsed by the Heart Failure Society of America1. J Hear Lung Transpl 21:189–203CrossRefGoogle Scholar
- 9.Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, Serruys PW (2009) Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 30(17):2102–2108CrossRefGoogle Scholar
- 23.Bazilevs Y, Gohean JR, Hughes TJR, Moser RD, Zhang Y (2009) Patient-specific isogeometric fluid–structure interaction analysis of thoracic aortic blood flow due to implantation of the Jarvik 2000 left ventricular assist device. Comput Methods Appl Mech Eng 198:3534–3550MathSciNetCrossRefGoogle Scholar
- 29.Gilani FS, Farooqui S, Doddamani R, Gruberg L (2015) Percutaneous mechanical support in cardiogenic shock: a review. Clin Med Insights Cardiol 9:23Google Scholar
- 30.Mehmanesh H (2013) US Patent No. 8,585,572. US Patent and Trademark Office, Washington, DCGoogle Scholar
- 33.Figueroa CA (2006) A coupled-momentum method to model blood flow and vessel deformation in human arteries: applications in disease research and simulation-based medical planning. Doctoral dissertation, Stanford UniversityGoogle Scholar